Chai Discovery

United States
activeseries-a
series-a
Stage
2025
Founded
3
Investors

About

Chai Discovery develops generative AI platforms that design antibodies and other biologic molecules at the atomic level to accelerate drug discovery and improve binding prediction without extensive experimental screening.

Explore Chai Discovery's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.